Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 12, 2021

SELL
$78.5 - $126.48 $15,700 - $25,296
-200 Closed
0 $0
Q3 2020

Oct 09, 2020

SELL
$45.65 - $61.81 $13,695 - $18,543
-300 Reduced 60.0%
200 $11,000
Q2 2020

Jul 07, 2020

SELL
$29.15 - $61.54 $17,490 - $36,924
-600 Reduced 54.55%
500 $30,000
Q1 2020

Apr 20, 2020

SELL
$25.01 - $42.4 $3,751 - $6,360
-150 Reduced 12.0%
1,100 $35,000
Q4 2019

Jan 27, 2020

BUY
$24.55 - $38.13 $30,687 - $47,662
1,250 New
1,250 $43,000
Q3 2019

Oct 09, 2019

SELL
$25.78 - $34.8 $32,225 - $43,500
-1,250 Closed
0 $0
Q2 2019

Aug 01, 2019

BUY
$23.08 - $37.01 $28,849 - $46,262
1,250 New
1,250 $36,000
Q4 2018

Jan 14, 2019

SELL
$28.91 - $50.0 $36,137 - $62,500
-1,250 Closed
0 $0
Q3 2018

Oct 18, 2018

BUY
$30.85 - $50.65 $38,562 - $63,312
1,250 New
1,250 $0

Others Institutions Holding STAA

About STAAR SURGICAL CO


  • Ticker STAA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 48,038,300
  • Market Cap $1.28B
  • Description
  • STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatis...
More about STAA
Track This Portfolio

Track True Private Wealth Advisors Portfolio

Follow True Private Wealth Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of True Private Wealth Advisors, based on Form 13F filings with the SEC.

News

Stay updated on True Private Wealth Advisors with notifications on news.